Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Dawnrays Pharmaceutical Holdings Ltd. ( (HK:2348) ) has shared an announcement.
Dawnrays Pharmaceutical Holdings Ltd. has announced a board meeting scheduled for August 22, 2025, to review and approve the interim results for the first half of the year ending June 30, 2025. The meeting will also consider the declaration of an interim dividend, reflecting the company’s ongoing financial assessment and potential shareholder returns.
More about Dawnrays Pharmaceutical Holdings Ltd.
Dawnrays Pharmaceutical Holdings Ltd. is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. The company focuses on the development, manufacture, and sale of pharmaceutical products, serving various market needs.
Average Trading Volume: 2,115,131
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$2.04B
See more data about 2348 stock on TipRanks’ Stock Analysis page.